S 1040 · 119th Congress
Drug Competition Enhancement Act
This bill is designed to make it easier for generic and biosimilar drugs to enter the market and compete with brand-name medications. Right now, pharmaceutical companies can use various legal strategies to delay competition, which keeps drug prices high. This bill aims to close some of those loopholes and speed up t…
- Sponsor
- Cornyn, John (R-Texas)
- Introduced
- 2025-03-13
- Policy area
- Health
- Latest action
- Placed on Senate Legislative Calendar under General Orders. Calendar No. 43.
Digging through Congress... 🔍